A Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects with Chronic Pseudomonas aeruginosa (PsA) Pulmonary Infection
Nebulized Bacteriophage Treatment for Chronic PA in CF
What is the goal of the study?
This Phase 1b/2a, randomized, double-blind, placebo-controlled, multicenter study will evaluate the safety and tolerability of nebulized BX004-A in adult patients with CF with chronic PsA pulmonary infection. There will be XX visits over XX weeks with study procedures to assess safety and microbiologic response.
Who can participate in the study?
Please contact the study team listed below to learn more.